Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1C | Q13936 | 2/20 | 0.46 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.46 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.46 |
| ▸ | HSD11B1 | P28845 | 6/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13478003 | 0.85 | CACNA1C (0.49) | CACNA1CSCN5AKCNH2HSD11B1SMN1; SMN2 | |
| SCHEMBL27576629 | 0.81 | CACNA1C (0.45) | CACNA1CSCN5AKCNH2HSD11B1SMN1; SMN2 | |
| SCHEMBL6178948 | 0.79 | HSD11B1 (0.45) | SCN5AKCNH2HSD11B1SMN1; SMN2CNR1 | |
| SCHEMBL14518469 | 0.78 | SCN5A (0.66) | CACNA1CSCN5AKCNH2HSD11B1CNR1 | |
| SCHEMBL22481162 | 0.77 | ADRB1 (0.60) | CACNA1CSCN5AKCNH2 | |
| SCHEMBL29675844 | 0.77 | CACNA1C (0.42) | CACNA1CSCN5AKCNH2SMN1; SMN2CNR1 | |
| SCHEMBL29860803 | 0.76 | PGK1 (0.41) | HSD11B1SMN1; SMN2 | |
| SCHEMBL4273303 | 0.76 | PGK1 (0.41) | HSD11B1SMN1; SMN2 | |
| SCHEMBL6178015 | 0.75 | CCNT1 (0.42) | HSD11B1SMN1; SMN2 | |
| SCHEMBL22937086 | 0.73 | CACNA1C (0.51) | CACNA1CSCN5AKCNH2HSD11B1CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0977735-B1 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2003-03-26 | — | — | EP | disclosed |
| US-6191304-B1 | REDUCTION OF AN ALKYL 3-ALKYLOXY-11-OXO-10,11-DIHYDRO-5H-DIBENZO(A,D)CYCLOHEPTEN-10-ACETATE BY HYDROGENOLYSIS USING A PALLADIUM/ACTIVATED CARBON CATALYST; INTERMEDIATES FOR3-((4-AMINOPYRID-2-YL)AMINOALKYLENEOXY) DERIVATIVES | SMITHKLINE BEECHAM CORPORATION | 2001-02-20 | — | — | US | disclosed |
| US-6069158-A | Vitronectin receptor antagonists | SMITHKLINE BEECHAM CORPORATION (US) | 2000-05-30 | — | — | US | disclosed |
| EP-0977735-A4 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORP (US) | 2000-04-05 | — | — | EP | disclosed |
| CN-1249745-A | Vitronectin receptor antagonists | SMITHKLINE BEECHAM CORP (US) | 2000-04-05 | — | — | CN | disclosed |
| EP-0977735-A1 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-02-09 | — | — | EP | disclosed |
| WO-1998030542-A1 | VITRONECTIN RECEPTOR ANTAGONISTS | SMITHKLINE BEECHAM CORPORATION (US) | 1998-07-16 | — | — | WO | disclosed |